Henry Schein (Nasdaq:HSIC) today announced its chief financial officer Steven Paladino will retire later this year and that Ronald South will replace him. Paladino’s is set to retire on April 29 after 35 years with the Melville, N.Y.-based dental supplier. He will remain a member of the board of directors and will become an adviser […]
Henry Schein
Former Blue Cross Blue Shield CEO joins Henry Schein board of directors
Henry Schein (Nasdaq: HSIC) announced today that it appointed Scott Serota as a member of its board of directors. Melville, N.Y.-based Henry Schein said in a news release that Serota will serve until the 2022 annual meeting of stockholders in May, at which point he is expected to stand for re-election to the board by […]
Baxter, 3M, Abbott near the top of Newsweek’s most responsible companies list
Several medtech, healthcare and life sciences companies, including big names like Abbott (NYSE:ABT), 3M (NYSE:MMM) and Baxter (NYSE:BAX), are among the 500 “most responsible,” according to Newsweek. The outlet published its “America’s Most Responsible Companies 2022” list, marking the third installment of the compilation (in partnership with Statista), this time expanded to include 500 of […]
Henry Schein beats the Street in Q3, increases EPS projections
Henry Schein (NSDQ:HSIC) shares ticked up today on third-quarter results that beat the consensus forecast. The Melville, New York-based company posted profits of $162.3 million, or $1.15 per share, on sales of $3.2 billion for the three months ended Sept. 25, 2021, for a 14.5% bottom-line gain on sales growth of 11.9%. Adjusted to exclude […]
Henry Schein promotes top lawyers
Henry Schein (Nasdaq: HSIC) has promoted four members of its legal team to high-ranking positions. The medical device manufacturer and distributor on Monday named SVP Walter Siegel as chief legal officer, Kelly Murphy as SVP and general counsel, Jennifer Ferrero as deputy secretary and Reid Arstark to senior counsel, mergers & acquisitions. Get the full […]
Henry Schein beats The Street in Q2 results, raises guidance
Henry Schein (NSDQ:HSIC) today posted second-quarter results that beat the overall consensus on Wall Street. The Melville, N.Y.-based company reported profits of $163.9 million, or $1.10 per share, on sales of $2.9 billion for the three months ended June 26, for a sales growth of 76.2% compared with Q2 2020. Adjusted to exclude one-time items, earnings […]
Henry Schein beats The Street in Q1, raises guidance
Henry Schein (NSDQ:HSIC) raised its 2021 guidance after reporting first-quarter financial results that topped the consensus forecast. The Melville, N.Y.-based company posted profits of $166 million, or $1.16 per share, on sales of $2.9 billion for the three months ended March 27, 2021, for a 27.4% bottom-line gain on sales growth of 20.4% year-over-year. Adjusted to […]
8 medical device companies that beat the COVID-19 pandemic and prospered
Some medical device businesses not only survived the COVID-19 pandemic but actually thrived — with many producing the medtech needed to fight the coronavirus’s spread. Medical Design & Outsourcing recently analyzed financials for 20 of the largest medical device businesses in the world. Not only was revenue only slightly down for the 20 during 2020, but it was […]
How big medtech fared during a year of COVID-19
Despite numerous challenges, the medtech industry showed itself to be fairly recession-proof in 2020, according to a Medical Design & Outsourcing/MassDevice analysis of financials. Annual reports recently released by 20 of the world’s largest medical device companies showed only a slight dip in revenue during 2020 — a year in which medtech held the front lines against […]
Henry Schein reinstates share repurchase program
Henry Schein (NSDQ:HSIC) announced today that it entered into amendments to reinstate its share repurchase program. Melville, N.Y.-based Henry Schein’s amendments to its private placement facility permit the company to reinstate the share repurchase program, according to a news release. The company said it had $201 million authorized and available for future stock repurchases at the […]
The top 7 medtech CEO quotes on COVID-19, one year later
The latest earnings season has provided insights into the future of medtech in the COVID-19 landscape and what certain sectors are seeing as vaccines start to roll out. Since the start of the pandemic, 113.1 million COVID-19 cases have been reported worldwide, according to Johns Hopkins University School of Medicine. The U.S. leads the world […]